Mish's Global Economic Trend Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Mish's Global Economic Trend Analysis

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Little Joe who wrote (98839)	6/23/2009 5:41:07 PM
From: benwood	4 Recommendations Read Replies (1) of 116555

The gov't may indeed do a lousy job of pharmaceutical research, as you suggest. However, with a friend who takes $3500 per month in medications for her Parkinson's, it occurs to me that no true breakthrough will be forthcoming from big Pharma to kill that golden goose. In theory, research sponsored by the gov't would do so because it would lower their cost burden in society. As is, there is zero incentive to solve the Parkinson's problem once and for all (ditto MS, Fragile X and others) and every incentive to find very, very expensive band-aides. The solution I think isn't gov't and it isn't pharma (for these at least) but instead groups like the Livestrong Foundation and the Michael J Fox Foundation for Parkinson's Research -- hopefully outside the bloated, inefficient gov't and outside the desire of phara to medicate us forever. edit: oh, and the solutions which will come from functional medical systems overseas. The FDA will block the drugs of course, but at least sufferers could move away and get a cure.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next